Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.63 |
| ▸ | ACACB | O00763 | 1/20 | 0.61 |
| ▸ | ACACA | Q13085 | 1/20 | 0.61 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.57 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.57 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | CPT2 | P23786 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | ARG2 | P78540 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 3/20 | 0.40 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.38 |
| ▸ | TTR | P02766 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28606082 | 1.00 | ACLY (0.63) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL6699125 | 1.00 | ACLY (0.63) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL6692276 | 1.00 | ACLY (0.63) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL8571217 | 0.98 | ACLY (0.59) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL5075315 | 0.95 | ACLY (0.56) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL9837397 | 0.93 | ACLY (0.54) | ACLYACACBACACACYP4F2CYP4A11 | |
| 1,6-Hexanediol SCHEMBL11319932 | 0.92 | ACLY (0.55) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL5528331 | 0.90 | ACLY (0.74) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL1836313 | 0.90 | ACLY (0.74) | ACLYACACBACACACYP4F2CYP4A11 | |
| SCHEMBL20474799 | 0.90 | ACLY (0.74) | ACLYACACBACACACYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479812-B2 | Fatty acid derivatives and their use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-11-25 | — | — | US | disclosed |
| US-11555021-B2 | Fatty acid derivatives and their use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-01-17 | — | — | US | disclosed |
| US-20220274940-A1 | FATTY ACID DERIVATIVES AND THEIR USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) | 2022-09-01 | — | — | US | disclosed |
| CN-110869354-A | Fatty acid derivatives and uses thereof | 美国政府(由卫生和人类服务部的部长所代表) | 2020-03-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220274940-A1 | FATTY ACID DERIVATIVES AND THEIR USE | FFAR3, FFAR1, FFAR2 | ACLY 2124/4885ACACB 468/4885ACACA 297/4885 |
| US-12479812-B2 | Fatty acid derivatives and their use | FFAR3, FFAR1, FFAR2 | ACLY 2124/4885ACACB 468/4885ACACA 297/4885 |
| US-11555021-B2 | Fatty acid derivatives and their use | FFAR3, FFAR1, FFAR2 | ACLY 2124/4885ACACB 468/4885ACACA 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.